This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Early Stocks in Motion

Express Scripts (ESRX - Get Report) after the bell Monday announced that it now expects 2006 earnings of $3.10 to $3.22 a share, including 10 cents in stock option expenses. Analysts polled by Thomson First Call project 2006 earnings of $2.98 a share. The pharmacy benefit manager said its financial performance will benefit from growth in generic utilization and home delivery, lower retail and home delivery costs, and increased productivity and other cost management plans. The company's shares gained $2.49, or 3.1%, to $82.38 in after-hours trading.

Applebee's International (APPB) reported a 0.7% increase in systemwide same-store sales for the November period. Franchise-owned restaurants saw same-store sales rise 1.4%, while same-store sales for company restaurants fell 1.4% amid a decrease in guest traffic. The casual-dining chain said its Midwest and New England markets continued to be weak. The stock was down a penny to $23.28 in after-hours trading.

Inter Parfums (IPAR - Get Report) announced its 2006 guidance after the bell Monday. The perfume and cosmetics maker said it expects to earn $16.9 million, or 83 cents a share, on sales of $301 million, for the year. The guidance includes about 3 cents a share in costs from stock-options expensing. Analysts on average predict 2006 earnings of 80 cents a share and sales of $305 million. "We are looking for earnings to increase at a faster rate than sales and for 2006 to be a record year for profits as well as sales for Inter Parfums," Jean Madar, chairman and CEO, said in a statement. Inter Parfums shares rose 32 cents, or 2.1%, to $15.75 in after-hours trading.

ViroPharma (VPHM) announced a 7 million-share public stock offering. Underwriters will have a 30-day option to purchase up to an additional 1 million shares. The drug company said the proceeds will be used for general corporate purposes. The stock fell $1.34, or 7.9%, to $15.66 after hours.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
VPHM $49.96 -0.02%
DNDN $0.06 -6.02%
SYNM $3.35 -1.18%
COP $47.79 0.00%
ESRX $73.73 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs